Single institution experience of recombinant activated factor VII (Novo-Seven) in the management of intractable bleeding in surgical and trauma patients.

被引：0
|
作者：
Alcorn, K
Aggarwal, A
机构：
[1] Washington Hosp Ctr, Dept Pathol, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Dept Hematol & Oncol, Washington, DC 20010 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3840
引用
收藏
页码：91B / 91B
页数：1
相关论文
共 50 条
  • [11] RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF INTRACTABLE NON-SURGICAL BLEEDING FOLLOWING MAJOR VASCULAR PROCEDURES
    Koncar, Igor B.
    Savic, Nebojsa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 199 - 203
  • [12] Management of severe sphincterotomy bleeding with recombinant activated factor VII
    Garrido-Serrano, Antonio
    GASTROINTESTINAL ENDOSCOPY, 2012, 76 (04) : 925 - 926
  • [13] Recombinant activated factor VII in the management of massive obstetric bleeding
    Palomino, MAP
    Chaparro, MJS
    De Elvira, MJZR
    Curiel, EB
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (03) : 226 - 227
  • [14] eComment. Activated recombinant factor VII in intractable bleeding after cardiac surgery
    Hajj-Chahine, Jamil
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (06) : 698 - 698
  • [15] Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery
    Dietrich, W
    Spannagl, M
    ANESTHESIA AND ANALGESIA, 2002, 94 (05): : 1369 - 1370
  • [16] Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures
    Uhrig, Lynn
    Blanot, Stephane
    Baugnon, Thomas
    Orliaguet, Gilles
    Carli, Pierre A.
    Meyer, Philippe G.
    PEDIATRIC CRITICAL CARE MEDICINE, 2007, 8 (06) : 576 - 579
  • [17] Use of Recombinant Activated Factor VII for Intractable Bleeding in Patients Without Hemophilia: A Developing Country Tertiary Care Center's Experience
    Musallam, Khaled M.
    Saad, George S. Abi
    Majdalani, Marianne N.
    Muwakkit, Samar A.
    Bou-Khalil, Pierre K.
    Aoun, Elie G.
    Sawaya, Raja A.
    Khalil, Ismail
    Taher, Ali T.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (06) : 658 - 662
  • [18] Management of bleeding emergencies: when to use recombinant activated Factor VII
    DeLoughery, TG
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (01) : 25 - 34
  • [19] An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
    Hendriks, HGD
    van der Maaten, JMAA
    de Wolf, J
    Waterbolk, TW
    Slooff, MJH
    van der Meer, J
    ANESTHESIA AND ANALGESIA, 2001, 93 (02): : 287 - 289
  • [20] Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery - Response
    Hendriks, HGD
    van der Maaten, JMAA
    de Wolf, JTM
    van der Meer, J
    ANESTHESIA AND ANALGESIA, 2002, 94 (05): : 1370 - 1371
12345